DK0854709T4 - Anvendelse af boswelliasyre og derivater deraf til hæmning af normal og foröget leukocytelastase- eller plasminaktivitet - Google Patents

Anvendelse af boswelliasyre og derivater deraf til hæmning af normal og foröget leukocytelastase- eller plasminaktivitet

Info

Publication number
DK0854709T4
DK0854709T4 DK96929309T DK96929309T DK0854709T4 DK 0854709 T4 DK0854709 T4 DK 0854709T4 DK 96929309 T DK96929309 T DK 96929309T DK 96929309 T DK96929309 T DK 96929309T DK 0854709 T4 DK0854709 T4 DK 0854709T4
Authority
DK
Denmark
Prior art keywords
plasmin activity
derivative
derivatives
boswellic acid
leukocyte elastase
Prior art date
Application number
DK96929309T
Other languages
English (en)
Other versions
DK0854709T3 (da
Inventor
Hermann P T Ammon
Hasan Safayhi
Original Assignee
Hermann P T Ammon
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=7770222&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DK0854709(T4) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Hermann P T Ammon filed Critical Hermann P T Ammon
Application granted granted Critical
Publication of DK0854709T3 publication Critical patent/DK0854709T3/da
Publication of DK0854709T4 publication Critical patent/DK0854709T4/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/20—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/22—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin
    • A61K31/225—Polycarboxylic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7028—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages
    • A61K31/7034—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages attached to a carbocyclic compound, e.g. phloridzin
    • A61K31/704—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages attached to a carbocyclic compound, e.g. phloridzin attached to a condensed carbocyclic ring system, e.g. sennosides, thiocolchicosides, escin, daunorubicin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/32—Burseraceae (Frankincense family)
    • A61K36/324—Boswellia, e.g. frankincense
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/08—Bronchodilators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/12—Drugs for disorders of the urinary system of the kidneys
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/08—Drugs for genital or sexual disorders; Contraceptives for gonadal disorders or for enhancing fertility, e.g. inducers of ovulation or of spermatogenesis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/06—Antimigraine agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Molecular Biology (AREA)
  • Microbiology (AREA)
  • Reproductive Health (AREA)
  • Emergency Medicine (AREA)
  • Mycology (AREA)
  • Medical Informatics (AREA)
  • Urology & Nephrology (AREA)
  • Pulmonology (AREA)
  • Botany (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Biotechnology (AREA)
  • Pregnancy & Childbirth (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Rheumatology (AREA)
  • Immunology (AREA)
  • Pain & Pain Management (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Endocrinology (AREA)
  • Neurosurgery (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Gynecology & Obstetrics (AREA)
  • Medicinal Preparation (AREA)
DK96929309T 1995-08-23 1996-08-22 Anvendelse af boswelliasyre og derivater deraf til hæmning af normal og foröget leukocytelastase- eller plasminaktivitet DK0854709T4 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE19531067A DE19531067A1 (de) 1995-08-23 1995-08-23 Verwendung von Boswelliasäure und ihren Derivaten zur Hemmung der normalen und gesteigerten Leukozytenelastase- oder Plasminaktivität
PCT/EP1996/003705 WO1997007796A1 (de) 1995-08-23 1996-08-22 Verwendung von boswelliasäure und ihren derivaten zur hemmung der normalen und gesteigerten leukozytenelastase- oder plasminaktivität

Publications (2)

Publication Number Publication Date
DK0854709T3 DK0854709T3 (da) 2001-06-18
DK0854709T4 true DK0854709T4 (da) 2005-04-11

Family

ID=7770222

Family Applications (1)

Application Number Title Priority Date Filing Date
DK96929309T DK0854709T4 (da) 1995-08-23 1996-08-22 Anvendelse af boswelliasyre og derivater deraf til hæmning af normal og foröget leukocytelastase- eller plasminaktivitet

Country Status (9)

Country Link
US (4) US20020010168A1 (da)
EP (1) EP0854709B2 (da)
JP (1) JPH11511448A (da)
AT (1) ATE200422T1 (da)
DE (2) DE19531067A1 (da)
DK (1) DK0854709T4 (da)
ES (1) ES2157005T5 (da)
PT (1) PT854709E (da)
WO (1) WO1997007796A1 (da)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TWI266760B (en) 2000-03-20 2006-11-21 Kvaerner Process Tech Ltd Process for the preparation of propane-1,3-diol
US6492429B1 (en) 2000-07-10 2002-12-10 N.V. Nutricia Composition for the treatment of osteoarthritis
DE10041217A1 (de) * 2000-08-22 2002-03-14 Henkel Kgaa Verwendung von Dihydroboswelliasäuren oder hydrierten Extrakten aus Boswellia zur prophylaktischen und/oder therapeutischen Behandlung von unerwünschten körperlichen oder seelischen Zuständen
WO2002024173A2 (de) * 2000-09-20 2002-03-28 R.P. Scherer Gmbh & Co. Kg Orale zubereitungsformen von extrakten aus boswellia
WO2002066491A1 (en) * 2001-02-15 2002-08-29 Sabinsa Corporation Water soluble boswellic acids, their preparation and use for treating imflammatory conditions
ITMI20031311A1 (it) * 2003-06-27 2004-12-28 Indena Spa Formulazioni per il trattamento di disturbi artrosici.
JP4390809B2 (ja) 2004-01-07 2009-12-24 イーエルシー マネージメント エルエルシー 発毛遅延のための化粧品組成物及び方法
US7893263B2 (en) * 2004-07-08 2011-02-22 Laila Nutraceuticals Structural analogs of corosolic acid having anti-diabetic and anti-inflammatory properties
RU2266748C1 (ru) * 2004-11-16 2005-12-27 Открытое акционерное общество Завод экологической техники и экопитания "ДИОД" /ОАО "ДИОД"/ Средство, обладающее противовоспалительной активностью
US8486423B2 (en) 2007-08-21 2013-07-16 Board Of Regents, The University Of Texas System Thermo-kinetic mixing for pharmaceutical applications
US20110052738A1 (en) * 2008-01-17 2011-03-03 Gary Dean Bennett Topical pain formulation
US20090298938A1 (en) * 2008-03-11 2009-12-03 Council Of Scientific & Industrial Research Use of semi synthetic analogues of boswellic acids for anticancer activity
DE102008017496A1 (de) 2008-04-04 2009-10-15 Medeon Pharmaceuticals Gmbh Verwendung von Boswelliasäure und Boswelliasäurederivaten zur Herstellung von Arzneimitteln zur Therapie von Multipler Sklerose
DE102008015607A1 (de) * 2008-03-26 2009-10-15 Universität Tübingen Verwendung von Boswelliasäuren und synthetischen Boswelliasäurederivaten zur Hemmung der mikrosomalen Prostaglandin E2 Synthase und des Cathepsin G
US20100112101A1 (en) * 2008-05-06 2010-05-06 Laila Impex Bio-availability/bio-efficacy enhancing activity of stevia rebaudiana and extracts and fractions and compounds thereof
DK3150198T3 (da) * 2010-04-07 2021-11-01 Vertex Pharma Farmaceutiske sammensætninger af 3-(6-(1-(2,2-difluorbenzo[d][1,3]dioxol-5-yl)-cyclopropancarboxamido)-3-methylpyriodin-2-yl)benzoesyre og indgivelse deraf
WO2012116238A1 (en) * 2011-02-23 2012-08-30 Dispersol Technologies, Llc PHARMACEUTICAL FORMULATIONS OF ACETYL-11-KETO-β-BOSWELLIC ACID, DIINDOLYLMETHANE, AND CURCUMIN FOR PHARMACEUTICAL APPLICATIONS
CN103889434B (zh) 2011-06-21 2017-02-15 Bvw控股公司 含有乳香酸的医疗装置
DE102017005429A1 (de) * 2017-06-08 2018-12-13 Adelheid Maria Zech Zubereitungen auf Basis Weihrauch zur Verwendung bei der Behandlung einer Erkrankung der Atmungswege eines Lebewesens
US9975917B1 (en) 2017-09-20 2018-05-22 King Saud University Pentacyclic triterpenoidal derivatives

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4501734A (en) * 1981-03-06 1985-02-26 Wakunaga Yakuhin Kabushiki Kaisha Promotion of absorption of drugs administered through the alimentary system
US5064823A (en) * 1988-08-24 1991-11-12 Research Triangle Institute Pentacyclic triterpenoid compounds as topoisomerase inhibitors or cell differentiation inducers
CA1330944C (en) † 1988-08-24 1994-07-26 De-Hua Li Pentacyclic triterpenoid compounds as topoisomerase inhibitors or cell differentiation inducers
DE4201903B4 (de) * 1992-01-24 2004-04-15 Hermann P.T. Prof. Dr.Med. Ammon Pharmazeutische Verwendung von Boswelliasäuren
US5494668A (en) * 1994-07-11 1996-02-27 Patwardhan; Bhushan Method of treating musculoskeletal disease and a novel composition therefor
DE4444288A1 (de) * 1994-12-13 1996-06-20 Rainer Dr Med Etzel Verwendung von Weihrauch zur Behandlung der Alzheimer-Krankheit
DE4445728A1 (de) † 1994-12-21 1996-06-27 Simmet Th Prof Dr Verwendung von Boswelliasäure zur Behandlung von Hirntumoren
US5629351A (en) * 1995-04-13 1997-05-13 Council Of Scientific & Industrial Research Boswellic acid compositions and preparation thereof
JPH10107808A (ja) * 1996-10-03 1998-04-24 Fujitsu Ltd セル交換システムにおける仮想コネクションの設定制御方式
US5888514A (en) * 1997-05-23 1999-03-30 Weisman; Bernard Natural composition for treating bone or joint inflammation

Also Published As

Publication number Publication date
US20070129317A1 (en) 2007-06-07
DE59606784D1 (de) 2001-05-17
EP0854709B2 (de) 2005-02-23
EP0854709A1 (de) 1998-07-29
ES2157005T3 (es) 2001-08-01
JPH11511448A (ja) 1999-10-05
US20050209169A1 (en) 2005-09-22
PT854709E (pt) 2001-08-30
US20020010168A1 (en) 2002-01-24
US20100166670A1 (en) 2010-07-01
DK0854709T3 (da) 2001-06-18
ES2157005T5 (es) 2005-07-16
EP0854709B1 (de) 2001-04-11
DE19531067A1 (de) 1997-02-27
WO1997007796A1 (de) 1997-03-06
ATE200422T1 (de) 2001-04-15

Similar Documents

Publication Publication Date Title
DK0854709T3 (da) Anvendelse af boswelliasyre og derivater deraf til hæmning af normal og forøget leukocytelastase- eller plasminaktivitet
NO20053077L (no) Terapeutiske formuleringer for behandling av beta-amyloid-relaterte sykdommer.
DE59907752D1 (de) Verwendung von erythropoietin oder erythropoietin-derivaten zur behandlung von cerebralen ischämien
DE60222137D1 (de) Zuckerderivate von hydromorphon, dihydromorphin und dihydroisomorphin, zusammensetzungen davon und verwendung zur vorbeugung und behandlung von schmerzen
IL139231A0 (en) Preparations for the application of anti-inflammatory, especially antiseptic, agents and/or agents promoting the healing of wounds to the lower respiratory tract
MX9300904A (es) Composiciones que contienen acido hialuronico
DK0796103T3 (da) Anvendelse af røgelse til behandling af Alzheimer-sygdommen
DK0573603T3 (da) Inhibitorer af human neutrofil elastase og human cathepsin G
ES2171933T3 (es) Derivados de androsteno.
ATE305469T1 (de) Sulfonsäure- oder sulfonylamino-n-(heteroaralkyl)-azaheterozyklyl midverbindungen
DE4394931T1 (de) Verwendung von Norastemizol zur Behandlung von allergischen Erkrankungen
DE60031016D1 (de) Verwendung von Antiseptika zur Herstellung von Arzneimitteln zur Prophylaxe und Behandlung von Entzündungen im Korperinneren des Menschen
WO2004100893A3 (en) Methods for treatment of inflammatory diseases using ct-3 or analogs thereof
ATE458471T1 (de) Formulierungen mit povidon-iod zur behandlung von wunden
RU2001118854A (ru) Оптически активное производное пиридил-4н-1,2,4-оксадиазина и его применение при лечении сосудистых заболеваний
MXPA02009603A (es) Terapias de dosis divididas con actividad de deterioro vascular.
ATE326959T1 (de) Verwendung von docosahexaensäure als wirkstoff bei der behandlung von lipodystrophie
DE69022206D1 (de) Aldosereduktasehemmer enthaltende Zubereitungen zur Behandlung von Geschwüren.
MC2203A1 (fr) Medicament contre la cryptosporidiose
IL110888A0 (en) Pharmaceutical compositions for the treatment of liver diseases comprising a benzothiazepine derivative
US20190000822A1 (en) Chlorine or bromine salts of cetylpyridinium for use in the treatment of cutaneous and acute porphyrias and psoriasis
HUP0200129A2 (hu) N-(3'4'-dimetoxi-cinnamoil)-antranilsav alkalmazása szívkoszorúér-műtéttel kapcsolatos cardiovascularis események megelőzésére vagy mérséklésére
UA31004A (uk) Спосіб профілактики і лікування нефролітіазу